A phase II evaluation of cediranib in the treatment of recurrent or persistent endometrial cancer: An NRG Oncology/Gynecologic Oncology Group (GOG) study

Autor: Bender, D.P., Sill, M., Lankes, H., Darus, C.J., Delmore, J., Rotmensch, J., Gray, H.J., Mannel, R.S., Schilder, J.M., Leslie, K.K., Reyes, H.D., Hunter, M., McCourt, C.K., Samuelson, M.
Zdroj: In Gynecologic Oncology May 2015 138 Supplement 1:2-2
Databáze: ScienceDirect
Externí odkaz: